PetCaseFinder

Peer-reviewed veterinary case report

Dog with brain tumor diagnosed using F-FDOPA PET scan

By Wang, Juwon et al.·Published in Frontiers in veterinary science·2025·College of Veterinary Medicine, South Korea·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Case Report:F-FDOPA PET in the clinical management of a dog with an intraventricular tumor suspected to be choroid plexus papilloma.

Species:
dog

Plain-English summary

An 8-year-old neutered male Miniature Poodle was brought in because he was lethargic, not eating, and had a seizure. After tests, including an MRI, the vet found a tumor in his brain that was suspected to be a choroid plexus papilloma. The dog started chemotherapy with prednisolone and cyclophosphamide, but his condition worsened over time. Unfortunately, he passed away 186 days after his initial visit, highlighting that despite some reduction in tumor size, the overall prognosis remained poor due to the tumor's aggressive nature and the dog's declining health.

People also search for: Miniature Poodle brain tumor symptoms · dog seizure treatment · choroid plexus papilloma in dogs · dog chemotherapy side effects

Abstract

An 8-year-old neutered male Miniature Poodle, weighing 6.7 kg, was presented with lethargy, anorexia, and single seizure episode. Neurological examination revealed bilaterally absent menace reflexes and an obtunded mental status. Magnetic resonance imaging showed a papilliform shaped mass measuring 1.2 × 1.4 × 1.3 cm in size, with a volume of 1.17 cmin the third ventricle. 3,4-dihydroxy-6-[F] fluoro-l-phenylalanine (F-FDOPA) positron emission tomography/computed tomography (PET/CT) was performed 53 days after presentation, revealing a hypermetabolic region in the intraventricular mass with mean and maximal standardized uptake values (SUVand SUV) of 1.2 and 1.42, respectively, and a tumor to normal tissue (T/N) ratio of 1.33. The mass lesion measured 1.3 × 1.4 × 1.2 cm in size, with a volume of 1.09 cmon contrast-enhanced CT images. The metabolic tumor volume (MTV) was 1.184No evidence of brain parenchymal metastases was observed. Therefore, the dog was tentatively diagnosed with a brain tumor, which was suspected to be a choroid plexus papilloma (CPP) and chemotherapy with prednisolone and cyclophosphamide was initiated. As worsening clinical signs were observed, a secondF-FDOPA PET/CT scan was performed on day 183. The SUV, SUV, and T/N ratio of the lesion were 1.49, 1.85, and 1.62, respectively. The mass lesion measured 1.0 × 1.0 × 1.3 cm in size, with a volume of 0.68 cmon contrast-enhanced CT images, whereas the MTV was increased to 2.217 cm. The dog died 186 days after the presentation. To the best of our knowledge, this is the first report describing theF-FDOPA PET/CT findings in a dog with an intraventricular brain tumor suspected of having CPP. In the present case, although the lesion size decreased on CT contrast imaging, an increase in the MTV was observed on follow-upF-FDOPA PET/CT after chemotherapy. Thus, an increase in MTV post-chemotherapy combined with the worsening clinical signs and limited survival period in dogs correlates with poor prognosis, as previously reported in a human study. This case offers significant diagnostic insights into canine intraventricular tumors within the field of veterinary medicine.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40206257/